PL2457563T3 - Stałe postacie dawkowania o zmodyfikowanym uwalnianiu rzędu zerowego - Google Patents

Stałe postacie dawkowania o zmodyfikowanym uwalnianiu rzędu zerowego

Info

Publication number
PL2457563T3
PL2457563T3 PL12156190T PL12156190T PL2457563T3 PL 2457563 T3 PL2457563 T3 PL 2457563T3 PL 12156190 T PL12156190 T PL 12156190T PL 12156190 T PL12156190 T PL 12156190T PL 2457563 T3 PL2457563 T3 PL 2457563T3
Authority
PL
Poland
Prior art keywords
zero
dosage forms
solid dosage
modified release
release solid
Prior art date
Application number
PL12156190T
Other languages
English (en)
Inventor
Suneel Kumar Rastogi
Justin Clark Meadows
Vishal Kumar Gupta
Original Assignee
Mallinckrodt Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Llc filed Critical Mallinckrodt Llc
Publication of PL2457563T3 publication Critical patent/PL2457563T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12156190T 2006-05-09 2007-05-09 Stałe postacie dawkowania o zmodyfikowanym uwalnianiu rzędu zerowego PL2457563T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79888906P 2006-05-09 2006-05-09
US85622606P 2006-11-01 2006-11-01

Publications (1)

Publication Number Publication Date
PL2457563T3 true PL2457563T3 (pl) 2017-09-29

Family

ID=38659385

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12156190T PL2457563T3 (pl) 2006-05-09 2007-05-09 Stałe postacie dawkowania o zmodyfikowanym uwalnianiu rzędu zerowego
PL12156178T PL2457562T3 (pl) 2006-05-09 2007-05-09 Stałe postacie dawkowania leku o zmodyfikowanym uwalnianiu o kinetyce rzędu zerowego

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL12156178T PL2457562T3 (pl) 2006-05-09 2007-05-09 Stałe postacie dawkowania leku o zmodyfikowanym uwalnianiu o kinetyce rzędu zerowego

Country Status (9)

Country Link
US (2) US20090110728A1 (pl)
EP (3) EP2457562B1 (pl)
JP (1) JP2009536654A (pl)
AU (1) AU2007249947B2 (pl)
CA (1) CA2651798C (pl)
ES (2) ES2626632T3 (pl)
MX (2) MX2008014059A (pl)
PL (2) PL2457563T3 (pl)
WO (1) WO2007133583A2 (pl)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1429739A1 (en) 2001-09-21 2004-06-23 Egalet A/S Polymer release system
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
DE602004031096D1 (de) 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
CN1893956A (zh) 2003-07-25 2007-01-10 沃纳奇尔科特公司 多西环素金属络合物固体剂型
NZ556582A (en) * 2005-01-21 2010-12-24 Warner Chilcott Co Llc A tetracycline metal complex in a solid dosage form
US20100104621A1 (en) * 2007-02-21 2010-04-29 Connected Health Systems, Llc Treating adhd and other diseases involving inflammation
AU2008258596B2 (en) 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
MX2009013384A (es) * 2007-06-08 2010-01-25 Addrenex Pharmaceuticals Inc Formulacion de liberacion extendida, y metodo para tratar disregulacion adrenergica.
US20090246276A1 (en) * 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
WO2010001413A2 (en) 2008-07-01 2010-01-07 Lupin Limited Sustained release pharmaceutical compositions comprising quetiapine
DE102008046650A1 (de) 2008-09-10 2010-03-11 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Quetiapin enthaltende Retardtablette
US20100151020A1 (en) * 2008-12-16 2010-06-17 Vered Rosenberger Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
PT2564839T (pt) 2009-01-09 2016-07-14 Forward Pharma As Formulação farmacêutica compreendendo um ou mais ésteres de ácido fumárico numa matriz de erosão
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
AU2011256928A1 (en) 2010-05-24 2012-12-20 Lupin Limited Extended release formulation of pramipexole
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
TR201008261A1 (tr) 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
US20120100214A1 (en) * 2010-10-21 2012-04-26 Galderma S.A. Sustained-Release Tablet and Process for Preparing the Same
SG189896A1 (en) 2010-10-21 2013-06-28 Galderma Sa Brimonidine gel compositions and methods of use
WO2012085656A2 (en) 2010-12-22 2012-06-28 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
KR20140075807A (ko) 2010-12-23 2014-06-19 퍼듀 퍼머 엘피 탬퍼 저항성 고체 경구 투여 형태
WO2012095746A2 (en) 2011-01-11 2012-07-19 Capsugel Belgium Nv New hard capsules
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
DK2688557T3 (da) * 2011-03-23 2017-11-27 Ironshore Pharmaceuticals & Dev Inc Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
AU2012256501B2 (en) 2011-05-13 2017-04-06 Eb Ip Hybritabs B.V. Drug delivery system
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CA2847614C (en) * 2011-09-30 2018-10-23 Mochida Pharmaceutical Co., Ltd. Easily dosable solid preparation
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
FR2986431B1 (fr) * 2012-02-03 2017-03-17 Servier Lab Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques
EP2812074B1 (en) 2012-02-08 2023-05-10 Supernus Pharmaceuticals, Inc. Modified release formulations of viloxazine
NZ704011A (en) 2012-07-06 2016-04-29 Egalet Ltd Abuse deterrent pharmaceutical compositions for controlled release
EP2822541B1 (en) 2012-09-10 2018-08-29 Pharmathen S.A. Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
MX2015010041A (es) 2013-02-05 2015-10-30 Purdue Pharma Lp Formulacion farmaceuticas resistentes a la alteracion.
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CA2964628A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2016115082A1 (en) * 2015-01-12 2016-07-21 Enteris Biopharma, Inc. Solid oral dosage forms
CN105982861B (zh) * 2015-02-11 2020-04-14 北京科信必成医药科技发展有限公司 一种阿奇霉素无水吞服掩味颗粒剂
US20180360817A1 (en) 2015-12-31 2018-12-20 Cadila Healthcare Limited Extended release osmotic dosage form comprising high methylphenidate hydrochloride load
ES2641308B1 (es) * 2016-05-05 2018-09-11 Products & Technology, S.L. Comprimidos de metilfenidato de liberación retardada
JP2018095566A (ja) * 2016-12-08 2018-06-21 アサヒグループ食品株式会社 水溶性機能性原料含有組成物、ソフトカプセル、及びソフトカプセルにおける水溶性機能性原料の減成抑制方法
CA3059529A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Process for making pullulan
CN110678170A (zh) 2017-04-14 2020-01-10 比利时胶囊公司 普鲁兰多糖胶囊
CN110025570A (zh) * 2019-05-25 2019-07-19 陕西中医药大学 新型中药蜂蜡块
CN110585154B (zh) * 2019-10-17 2021-07-02 武汉光谷亚太医药研究院有限公司 一种琥珀酸美托洛尔微丸压片的方法
WO2022241255A1 (en) * 2021-05-14 2022-11-17 Ocumedic, Inc. Extended-wear silicone hydrogel contact lenses and uses thereof
US20230240998A1 (en) * 2021-12-22 2023-08-03 Hikma Pharmaceuticals Usa Inc. Tofacitinib extended release formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US6673367B1 (en) 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US6500459B1 (en) * 1999-07-21 2002-12-31 Harinderpal Chhabra Controlled onset and sustained release dosage forms and the preparation thereof
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US7094469B2 (en) * 2001-08-28 2006-08-22 Mykrolis Corporation Porous or non-porous substrate coated with an immobilized polymeric composition having sulfonyl groups and hydrophilic functional groups and process
CA2470636A1 (en) * 2001-12-20 2003-07-03 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
KR100540035B1 (ko) * 2002-02-01 2005-12-29 주식회사 태평양 다단계 경구 약물 방출 제어 시스템
US20040241234A1 (en) * 2003-06-02 2004-12-02 Alpharma, Inc. Controlled release press-coated formulations of water-soluble active agents
KR20070036797A (ko) * 2004-07-26 2007-04-03 테바 파마슈티컬 인더스트리즈 리미티드 장용 코팅된 중심정을 갖는 제형
CA2576386A1 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof

Also Published As

Publication number Publication date
US20090110728A1 (en) 2009-04-30
WO2007133583A2 (en) 2007-11-22
EP2457563B1 (en) 2017-03-22
MX2008014059A (es) 2008-11-14
WO2007133583A3 (en) 2008-05-22
AU2007249947B2 (en) 2013-03-21
ES2627127T3 (es) 2017-07-26
US20190358164A1 (en) 2019-11-28
JP2009536654A (ja) 2009-10-15
CA2651798C (en) 2015-07-21
EP2457562B1 (en) 2017-04-05
ES2626632T3 (es) 2017-07-25
EP2020995A2 (en) 2009-02-11
AU2007249947A1 (en) 2007-11-22
EP2457563A1 (en) 2012-05-30
CA2651798A1 (en) 2007-11-22
MX350380B (es) 2017-09-05
EP2457562A1 (en) 2012-05-30
PL2457562T3 (pl) 2017-09-29

Similar Documents

Publication Publication Date Title
PL2457563T3 (pl) Stałe postacie dawkowania o zmodyfikowanym uwalnianiu rzędu zerowego
ZA200904436B (en) Modified release ibuprofen solid oral dosage form
ME01550B (me) Farmaceutski dozni oblici
HK1127356A1 (en) Pharmaceutical compounds
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
GB0608820D0 (en) Pharmaceutical compounds
EP1992348A4 (en) PHARMACEUTICAL COMBINATION
IL194366A0 (en) Solid dosage formulations
PL2002828T3 (pl) Stały preparat farmaceutyczny
GB0616794D0 (en) Solid dosage form
GB0608176D0 (en) Pharmaceutical Compounds
GB0608184D0 (en) Pharmaceutical compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
PL1984570T3 (pl) Urządzenie pługa
IL178378A0 (en) Extended release pharmaceutical compositions
GB0608179D0 (en) Pharmaceutical compounds
GB0615299D0 (en) Pharmaceutical compounds
GB0615293D0 (en) Pharmaceutical compounds
GB0614456D0 (en) Pharmaceutical compounds
GB0613520D0 (en) Pharmaceutical compounds
GB0625431D0 (en) Pharmaceutical compounds
GB0608185D0 (en) Pharmaceutical Compounds